BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28561278)

  • 1. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
    Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
    Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
    BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese men.
    Hoermann R; Fui MNT; Krakauer JC; Krakauer NY; Grossmann M
    Int J Obes (Lond); 2019 Nov; 43(11):2210-2216. PubMed ID: 30622310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.
    Hoyos CM; Yee BJ; Phillips CL; Machan EA; Grunstein RR; Liu PY
    Eur J Endocrinol; 2012 Oct; 167(4):531-41. PubMed ID: 22848006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
    Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
    Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
    Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
    JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.
    Sinclair M; Grossmann M; Hoermann R; Angus PW; Gow PJ
    J Hepatol; 2016 Nov; 65(5):906-913. PubMed ID: 27312945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
    J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
    Bhasin S; Storer TW; Javanbakht M; Berman N; Yarasheski KE; Phillips J; Dike M; Sinha-Hikim I; Shen R; Hays RD; Beall G
    JAMA; 2000 Feb; 283(6):763-70. PubMed ID: 10683055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet.
    Ng Tang Fui M; Hoermann R; Grossmann M
    J Endocr Soc; 2017 Apr; 1(4):302-312. PubMed ID: 29264488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial.
    Ng Tang Fui M; Hoermann R; Nolan B; Clarke M; Zajac JD; Grossmann M
    Sci Rep; 2018 Jun; 8(1):9099. PubMed ID: 29904126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?
    O'Connell MD; Roberts SA; Srinivas-Shankar U; Tajar A; Connolly MJ; Adams JE; Oldham JA; Wu FC
    J Clin Endocrinol Metab; 2011 Feb; 96(2):454-8. PubMed ID: 21084399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.